Analysis of the 42,000 public comments submitted to the Drug Enforcement Administration (DEA) regarding cannabis rescheduling shows ‘overwhelming support’ for reform.
New analysis from cannabis data platform Headset shows an ‘unprecedented’ level of engagement from the American public, with the response to cannabis rescheduling breaking the previous engagement record of 38,000 comments, submitted in 2020 regarding controversial telemedicine rules, comfortably.
More importantly, the vast majority of responses submitted were in favour of the proposals to move cannabis from a Schedule I substance to Schedule III, with many suggesting that the DEA should go even further and deschedule cannabis altogether.
According to Headset’s analysis, 92.45% of comments were in favour of changing cannabis’s schedule in the Controlled Substances Act (CSA), meaning just 7.55% of respondents were against the change.
Furthermore, the majority of respondents (61.7%) called for cannabis to be descheduled completely, while 38.3% supported rescheduling to a less restrictive category.
“This overwhelming show of public support, equivalent to the unanimous voice of an entire state capital, sends a powerful message to policymakers. It suggests that not only is there broad backing for the proposed rescheduling, but there’s also a significant push for even more comprehensive reform,” the company stated.
A number of key themes were also revealed during Headset’s analysis. One ‘notable phenomenon’ was the appearance of distinct spikes in comments opposing rescheduling that coincided with coordinated efforts by opposition groups.
One significant instance occurred on July 15, when Smart Approaches to Marijuana (SAM), an organization against cannabis legalization, issued a call to action to its supporters. SAM provided a form letter and urged supporters to submit comments, resulting in a noticeable surge in opposition submissions on that day.
These findings underscore the impact of organized advocacy groups on public comment periods and highlight the importance of examining both the content and timing of comments to fully understand public sentiment.
Despite the overwhelming public support for the rescheduling, a number of significant challenges remain, including the potential waning of political support for the move should no progress be made before November’s presidential election.
Home / Over 90% of Cannabis Rescheduling Comments Are in Favour of the Move, With the Majority Calling for Further Reform
Over 90% of Cannabis Rescheduling Comments Are in Favour of the Move, With the Majority Calling for Further Reform
Analysis of the 42,000 public comments submitted to the Drug Enforcement Administration (DEA) regarding cannabis rescheduling shows ‘overwhelming support’ for reform.
New analysis from cannabis data platform Headset shows an ‘unprecedented’ level of engagement from the American public, with the response to cannabis rescheduling breaking the previous engagement record of 38,000 comments, submitted in 2020 regarding controversial telemedicine rules, comfortably.
More importantly, the vast majority of responses submitted were in favour of the proposals to move cannabis from a Schedule I substance to Schedule III, with many suggesting that the DEA should go even further and deschedule cannabis altogether.
According to Headset’s analysis, 92.45% of comments were in favour of changing cannabis’s schedule in the Controlled Substances Act (CSA), meaning just 7.55% of respondents were against the change.
Furthermore, the majority of respondents (61.7%) called for cannabis to be descheduled completely, while 38.3% supported rescheduling to a less restrictive category.
“This overwhelming show of public support, equivalent to the unanimous voice of an entire state capital, sends a powerful message to policymakers. It suggests that not only is there broad backing for the proposed rescheduling, but there’s also a significant push for even more comprehensive reform,” the company stated.
A number of key themes were also revealed during Headset’s analysis. One ‘notable phenomenon’ was the appearance of distinct spikes in comments opposing rescheduling that coincided with coordinated efforts by opposition groups.
One significant instance occurred on July 15, when Smart Approaches to Marijuana (SAM), an organization against cannabis legalization, issued a call to action to its supporters. SAM provided a form letter and urged supporters to submit comments, resulting in a noticeable surge in opposition submissions on that day.
These findings underscore the impact of organized advocacy groups on public comment periods and highlight the importance of examining both the content and timing of comments to fully understand public sentiment.
Despite the overwhelming public support for the rescheduling, a number of significant challenges remain, including the potential waning of political support for the move should no progress be made before November’s presidential election.
European Cannabis
Insights Summit
200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.
Ben Stevens
Other featured articles
‘Not Immediately Compliant’: What the CRS Says America’s Rescheduling Order Actually Delivers
By
The War on Europe’s Legal Hemp Industry
By
DEA’s Schedule III Cannabis Order: A Free-For-All for Telehealth Platforms, or the Perfect Setup for the Entire Industry?
By
Cannabis Europa London 2026: The First Major Gathering Since Rescheduling Changed the Game
By
The Fight for Cannabis Rescheduling Is Far From Over
By
Other featured Data & Analysis articles
The Fight for Cannabis Rescheduling Is Far From Over
By
Does the UK Media’s Cannabis Coverage Reflect Public Opinion? The Data Says No
By
Germany Now Represents 62% of Canadian Cannabis Flower Exports as Portugal’s Share Collapses
By
Züri Can Extended By Two Years As Results Point To Black Market Deterrence
By
Germany’s Cannabis Reform Shows No Signs of Harm its Critics Predicted, Government Mandated Data Shows
By
Share Article
The Briefing / Newsletter
Insights
you don't want
to miss.
A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.
Related news
‘Not Immediately Compliant’: What the CRS Says America’s Rescheduling Order Actually Delivers
By
The War on Europe’s Legal Hemp Industry
By
DEA’s Schedule III Cannabis Order: A Free-For-All for Telehealth Platforms, or the Perfect Setup for the Entire Industry?
By
Cannabis Europa London 2026: The First Major Gathering Since Rescheduling Changed the Game
By
The Fight for Cannabis Rescheduling Is Far From Over
By
The US Officially Reschedules Cannabis, Partly….
By
Federal Agencies Reportedly Told to Prep for Imminent Cannabis Rescheduling Announcement
By
Does the UK Media’s Cannabis Coverage Reflect Public Opinion? The Data Says No
By
Cannabis Industry Council Releases Global Guide for Patients Travelling with Medical Cannabis
By